JBM (Healthcare) Limited

HKEX:2161.HK

0.9 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q2
Revenue 321.587326.828283.475236.848216.767189.372201.053196.105
Cost of Revenue 154.628155.706163.509151.305130.337114.292105.02693.699
Gross Profit 166.959171.122119.96685.54386.4375.0896.027102.406
Gross Profit Ratio 0.5190.5240.4230.3610.3990.3960.4780.522
Reseach & Development Expenses 00000000
General & Administrative Expenses 16.41225.27335.39318.38419.66221.76223.11318.703
Selling & Marketing Expenses 71.56666.96142.71841.24342.55438.67142.25343.452
SG&A 87.97892.23478.11159.62764.71660.43365.36662.155
Other Expenses 00000000
Operating Expenses 87.97892.23478.11159.62764.71660.43365.36662.155
Operating Income 78.98178.88841.85525.91621.71414.64730.66140.251
Operating Income Ratio 0.2460.2410.1480.1090.10.0770.1530.205
Total Other Income Expenses Net 5.0622.7767.2843.776-1.392-2.433-24.076-3.969
Income Before Tax 84.04381.66449.13929.69220.32212.2146.58536.282
Income Before Tax Ratio 0.2610.250.1730.1250.0940.0640.0330.185
Income Tax Expense 11.4816.28.0145.5564.5122.9053.7617.301
Net Income 68.00262.46135.53221.56114.5810.040.9521.65
Net Income Ratio 0.2110.1910.1250.0910.0670.0530.0050.11
EPS 0.0790.0690.0390.0240.0160.0110.0010.024
EPS Diluted 0.0790.0690.0390.0240.0160.0110.0010.024
EBITDA 101.487102.90361.86349.5445.78338.36153.3761.144
EBITDA Ratio 0.3160.3150.2180.2090.2110.2030.2650.312